U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT06838104) titled 'Effect of Melatonin on Schizophrenic Symptoms: a Randomized Placebo-Controlled Trial' on Feb. 15.
Brief Summary: Schizophrenia is a chronic mental health disorder that affects thoughts, emotions, and behaviors. It includes positive symptoms such as hallucinations and delusions, as well as negative symptoms like reduced motivation, social withdrawal, and blunted emotional expression. While antipsychotic medications are the primary treatment, they often fail to fully address negative symptoms, which are strongly associated with poor functional outcomes.
This study is a randomized, placebo-controlled trial designed to evaluate the eff...